BRK-B vs DNP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DNP exhibits a stable financial profile with a Piotroski F-Score of 5/9 and a strong defensive valuation, trading significantly below its Graham Number of $15.59. While the fund offers an attractive dividend yield of 7.28% and low leverage (Debt/Equity 0.32), it is currently facing a severe earnings contraction of -73.40% YoY. The discrepancy between the bearish technical trend score (10/100) and the positive 1-year price performance (+21.3%) suggests a potential divergence between short-term momentum and long-term fundamentals. Overall, it remains a viable income vehicle, but the sharp decline in earnings growth limits a bullish rating.
Compare Another Pair
Related Comparisons
BRK-B vs DNP: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and DNP Select Income Fund Inc. (DNP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.